ELEVANCE HEALTH, INC. for ELEVANCE HEALTH, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
General Issues related to the Patient Protection and Affordable Care Act (PPACA), including: Implementation and insurer tax General Issues: corporate tax reform and tax treatment of health insurers.Specific Bills include: HIT tax repeal and delay bills - H.R. 3367; H.R. 763; and, S.603.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GOLDBERG | — |
| ELIZABETH HALL | — |
| ERIKA LONG | — |
| SAMUEL JOHN MARCHIO | — |
| MARY KATHLEEN ZIRKELBACH | — |
Health Issues HCR
General Issues related to the Patient Protection and Affordable Care Act (PPACA), including: Implementation, essential health benefits, exchanges, medical loss ratio, insurer tax, rate review, rate development, enrollment and re-enrollment, plan benefit design, grandfathering, Medicare, discontinuation of health plans, and ACA risk mitigation provisions.General Issues: Quality and care coordination, innovation, affordability, ICD-10, consumer engagement, utilization trends, payment reform, fraud and abuse prevention, cost-sharing, wellness, advanced imaging management, telehealth, sustainable growth rate, Watson, payment reconciliation and high cost drugs. Specific Bills include: H.R. 3367; H.R. 763; S. 603; S.2214; H.R. 3489; H.R. 3541; H.R. 3812; H.R. 3750; H.R. 3077; S. 1787 and, H.R. 3306
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GOLDBERG | — |
| ELIZABETH HALL | — |
| ERIKA LONG | — |
| SAMUEL JOHN MARCHIO | — |
| MARY KATHLEEN ZIRKELBACH | — |
Medicare/Medicaid MMM
General Issues: Coordinated care for dual eligible's, Medicare payment reform, Medicare Advantage quality bonus payment program, insurer tax, Medicaid payment reform, Medicaid Managed Care, Medicare Advantage, Medicare Supplemental, fraud and abuse prevention, high cost drugs, Special Needs Plans reauthorization, Medicare Part D, appropriate use criteria, Medicare Sustainable Growth Rate, and Medicare data transparency.Specific Bills include: H.R. 4418; S. 1758; and, H.R. 4302 (became Public Law 113-93).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GOLDBERG | — |
| ELIZABETH HALL | — |
| ERIKA LONG | — |
| SAMUEL JOHN MARCHIO | — |
| MARY KATHLEEN ZIRKELBACH | — |
Insurance INS
General Issues related to the Patient Protection and Affordable Care Act (PPACA), including: Implementation, essential health benefits, exchanges, medical loss ratio, insurer tax, rate review, rate development, enrollment and re-enrollment, plan benefit design, grandfathering, Medicare, discontinuation of health plans, and ACA risk mitigation provisions.General Issues: Quality and care coordination, innovation, affordability, ICD-10, consumer engagement, utilization trends, payment reform, fraud and abuse prevention, cost-sharing, wellness, advanced imaging management, telehealth, sustainable growth rate, Watson, payment reconciliation and high cost drugs. Specific Bills include: H.R. 3367; H.R. 763; S. 603; S.2214; H.R. 3489; H.R. 3541; H.R. 3812; H.R. 3750; H.R. 3077; S. 1787 and, H.R. 3306
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM GOLDBERG | — |
| ELIZABETH HALL | — |
| ERIKA LONG | — |
| SAMUEL JOHN MARCHIO | — |
| MARY KATHLEEN ZIRKELBACH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.